Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-108761
Filing Date
2025-11-12
Accepted
2025-11-12 08:08:15
Documents
3
Period of Report
2025-11-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0265246-6k_alterity.htm 6-K 13823
2 ALTERITY TO PRESENT AT THE BELL POTTER HEALTHCARE CONFERENCE ea026524601ex99-1_alterity.htm EX-99.1 13320
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4258
  Complete submission text file 0001213900-25-108761.txt   34349
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 251469114
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)